Sign in

    Zach Adash

    Vice President and Equity Research Analyst at Stephens Inc.

    Zach Adash is a Vice President and Equity Research Analyst at Stephens Inc., specializing in the coverage of the industrials sector with a particular focus on industrial distribution and services companies. Throughout his tenure at Stephens Inc., he has provided in-depth analysis on firms such as Fastenal, SiteOne Landscape Supply, and Beacon Roofing Supply, demonstrating a detail-oriented and data-driven approach to stock recommendations. Adash began his career in equity research and joined Stephens Inc. after holding analyst roles at other financial institutions, accumulating a breadth of experience in evaluating operational performance and market strategies. He holds FINRA Series 7, 63, 86, and 87 licenses, underscoring his professional qualifications and commitment to rigorous investment analysis.

    Zach Adash's questions to BIOLIFE SOLUTIONS (BLFS) leadership

    Zach Adash's questions to BIOLIFE SOLUTIONS (BLFS) leadership • Q2 2025

    Question

    An analyst from Stephens Inc. asked for management's outlook on the EVO and THAW business segments and how they fit into the company's long-term portfolio, particularly given the focus on cell processing. He also inquired about demand trends in the early-stage clinical portion of the media business amid ongoing funding challenges.

    Answer

    Chairman & CEO Roderick de Greef stated that the EVO product line is still under evaluation for its long-term strategic fit, while the Thaw product line is considered a definite part of the portfolio due to its consistent revenue generation. Regarding early-stage clinical demand, de Greef acknowledged that while all customer segments grew year-over-year, the 'other clinical customers' (smaller, earlier-stage) showed the lightest growth, indicating some softness, but still positive year-over-year performance.

    Ask Fintool Equity Research AI